These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 32483445)
1. DR-region of Na Sun HJ; Cao L; Zhu MY; Wu ZY; Shen CY; Nie XW; Bian JS Theranostics; 2020; 10(14):6149-6166. PubMed ID: 32483445 [TBL] [Abstract][Full Text] [Related]
2. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes. Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094 [TBL] [Abstract][Full Text] [Related]
3. DR region of NKAα1 is a target to ameliorate hepatic lipid metabolism disturbance in obese mice. Sun HJ; Tan JX; Shan XD; Wang ZC; Wu ZY; Bian JS; Nie XW Metabolism; 2023 Aug; 145():155579. PubMed ID: 37127227 [TBL] [Abstract][Full Text] [Related]
4. Anti-Na Zheng J; Lan P; Li M; Kang MC; Xun M; Ma X; Yan M; Sun D; Shen Y; Fu X; Ding X; Yan X; Xue WJ Int Immunopharmacol; 2023 Mar; 116():109826. PubMed ID: 36764269 [TBL] [Abstract][Full Text] [Related]
5. Targeting NKAα1 to treat Parkinson's disease through inhibition of mitophagy-dependent ferroptosis. Zhang X; Li G; Chen H; Nie XW; Bian JS Free Radic Biol Med; 2024 Jun; 218():190-204. PubMed ID: 38574977 [TBL] [Abstract][Full Text] [Related]
6. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice. Chen Z; Ding L; Yang W; Wang J; Chen L; Chang Y; Geng B; Cui Q; Guan Y; Yang J Diabetes; 2017 May; 66(5):1185-1197. PubMed ID: 28246289 [TBL] [Abstract][Full Text] [Related]
7. FAM3A activates PI3K p110α/Akt signaling to ameliorate hepatic gluconeogenesis and lipogenesis. Wang C; Chi Y; Li J; Miao Y; Li S; Su W; Jia S; Chen Z; Du S; Zhang X; Zhou Y; Wu W; Zhu M; Wang Z; Yang H; Xu G; Wang S; Yang J; Guan Y Hepatology; 2014 May; 59(5):1779-90. PubMed ID: 24806753 [TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis. Wang J; Yang W; Chen Z; Chen J; Meng Y; Feng B; Sun L; Dou L; Li J; Cui Q; Yang J Diabetes; 2018 Apr; 67(4):581-593. PubMed ID: 29382663 [TBL] [Abstract][Full Text] [Related]
10. NFE2 Induces miR-423-5p to Promote Gluconeogenesis and Hyperglycemia by Repressing the Hepatic FAM3A-ATP-Akt Pathway. Yang W; Wang J; Chen Z; Chen J; Meng Y; Chen L; Chang Y; Geng B; Sun L; Dou L; Li J; Guan Y; Cui Q; Yang J Diabetes; 2017 Jul; 66(7):1819-1832. PubMed ID: 28411267 [TBL] [Abstract][Full Text] [Related]
11. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis. Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855 [TBL] [Abstract][Full Text] [Related]
12. Angiopoietin-like protein 8 (betatrophin) inhibits hepatic gluconeogenesis through PI3K/Akt signaling pathway in diabetic mice. Zhao Z; Deng X; Jia J; Zhao L; Wang C; Cai Z; Guo C; Yang L; Wang D; Ma S; Deng J; Li H; Zhou L; Tu Z; Yuan G Metabolism; 2022 Jan; 126():154921. PubMed ID: 34715116 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase. Zheng H; Wan J; Shan Y; Song X; Jin J; Su Q; Chen S; Lu X; Yang J; Li Q; Song Y; Li B Theranostics; 2021; 11(16):7829-7843. PubMed ID: 34335967 [No Abstract] [Full Text] [Related]
18. Catalpol ameliorates hepatic insulin resistance in type 2 diabetes through acting on AMPK/NOX4/PI3K/AKT pathway. Yan J; Wang C; Jin Y; Meng Q; Liu Q; Liu Z; Liu K; Sun H Pharmacol Res; 2018 Apr; 130():466-480. PubMed ID: 29284152 [TBL] [Abstract][Full Text] [Related]
19. Gdf11 gene transfer prevents high fat diet-induced obesity and improves metabolic homeostasis in obese and STZ-induced diabetic mice. Lu B; Zhong J; Pan J; Yuan X; Ren M; Jiang L; Yang Y; Zhang G; Liu D; Zhang C J Transl Med; 2019 Dec; 17(1):422. PubMed ID: 31847906 [TBL] [Abstract][Full Text] [Related]
20. Hepatic miR-125b inhibits insulin signaling pathway by targeting PIK3CD. Du X; Li X; Chen L; Zhang M; Lei L; Gao W; Shi Z; Dong Y; Wang Z; Li X; Liu G J Cell Physiol; 2018 Aug; 233(8):6052-6066. PubMed ID: 29319168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]